Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”

Ross L. Prentice; Aaron K. Aragaki; Rowan T. Chlebowski; Shanshan Zhao; Garnet L. Anderson; Jacques E. Rossouw; Robert Wallace; Hailey Banack; Aladdin H. Shadyab; Lihong Qi; Beverly M. Snively; Margery Gass; Jo Ann E. Manson

doi:10.1093/aje/kwaa032

Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”

Ross L. Prentice, Aaron K. Aragaki, Rowan T. Chlebowski, Shanshan Zhao, Garnet L. Anderson, Jacques E. Rossouw, Robert Wallace, Hailey Banack, Aladdin H. Shadyab, Lihong Qi, Beverly M. Snively, Margery Gass, Jo Ann E. Manson

Public Health Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	985-986
Number of pages	2
Journal	American journal of epidemiology
Volume	189
Issue number	9
DOIs	https://doi.org/10.1093/aje/kwaa032
State	Published - Sep 1 2020

ASJC Scopus subject areas

Epidemiology

Access to Document

10.1093/aje/kwaa032

Cite this

Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”. / Prentice, Ross L.; Aragaki, Aaron K.; Chlebowski, Rowan T.; Zhao, Shanshan; Anderson, Garnet L.; Rossouw, Jacques E.; Wallace, Robert; Banack, Hailey; Shadyab, Aladdin H.; Qi, Lihong; Snively, Beverly M.; Gass, Margery; Manson, Jo Ann E.

In: American journal of epidemiology, Vol. 189, No. 9, 01.09.2020, p. 985-986.

Research output: Contribution to journal › Comment/debate › peer-review

Prentice, Ross L. ; Aragaki, Aaron K. ; Chlebowski, Rowan T. ; Zhao, Shanshan ; Anderson, Garnet L. ; Rossouw, Jacques E. ; Wallace, Robert ; Banack, Hailey ; Shadyab, Aladdin H. ; Qi, Lihong ; Snively, Beverly M. ; Gass, Margery ; Manson, Jo Ann E. / Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”. In: American journal of epidemiology. 2020 ; Vol. 189, No. 9. pp. 985-986.

@article{2c520f6327bf4f849c67bb2e33bb03a5,

title = "Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”",

author = "Prentice, {Ross L.} and Aragaki, {Aaron K.} and Chlebowski, {Rowan T.} and Shanshan Zhao and Anderson, {Garnet L.} and Rossouw, {Jacques E.} and Robert Wallace and Hailey Banack and Shadyab, {Aladdin H.} and Lihong Qi and Snively, {Beverly M.} and Margery Gass and Manson, {Jo Ann E.}",

note = "Funding Information: Author affiliations: Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington (Ross L. Prentice, Aaron K. Aragaki, Garnet L. Anderson); Division of Medical Oncology/Hematology, Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, California (Rowan T. Chlebowski); Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (Shanshan Zhao); Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland (Jacques E. Rossouw); Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa (Robert Wallace); Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo, New York (Hailey Banack); Department of Family Medicine and Public Health, School of Medicine, University of California, San Diego, San Diego, California (Aladdin H. Shadyab); Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, California (Lihong Qi); Department of Biostatistics and Data Science, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina (Beverly M. Snively); North American Menopause Society, Mayfield Heights, Ohio (Margery Gass); and Brigham and Women{\textquoteright}s Hospital, Harvard Medical School, Boston, Massachusetts (JoAnn E. Manson). This work was supported by the National Cancer Institute (grants R01 CA119171 and R01 CA210921) and by the National Heart, Lung and Blood Institute, which supports the infrastructure of the Women{\textquoteright}s Health Initiative (contracts HHSN268201100046C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C, and HHSN271201600004C). R.T.C. reports consulting arrangements with Novartis International AG (Basel, Switzerland), AstraZeneca AB (Cambridge, United Kingdom), Amgen, Inc. (Thousand Oaks, California), Immunomedics (Morris Plains, New Jersey), Puma Biotechnology, Inc. (Los Angeles, California), and Genentech, Inc. (South San Francisco, California). The other authors have no pertinent disclosures.",

year = "2020",

month = sep,

day = "1",

doi = "10.1093/aje/kwaa032",

language = "English (US)",

volume = "189",

pages = "985--986",

journal = "American Journal of Epidemiology",

issn = "0002-9262",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Prentice et al. Respond to ⇜studying co-occurrence of multiple outcomes”

AU - Prentice, Ross L.

AU - Aragaki, Aaron K.

AU - Chlebowski, Rowan T.

AU - Zhao, Shanshan

AU - Anderson, Garnet L.

AU - Rossouw, Jacques E.

AU - Wallace, Robert

AU - Banack, Hailey

AU - Shadyab, Aladdin H.

AU - Qi, Lihong

AU - Snively, Beverly M.

AU - Gass, Margery

AU - Manson, Jo Ann E.

N1 - Funding Information: Author affiliations: Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington (Ross L. Prentice, Aaron K. Aragaki, Garnet L. Anderson); Division of Medical Oncology/Hematology, Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, California (Rowan T. Chlebowski); Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (Shanshan Zhao); Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland (Jacques E. Rossouw); Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa (Robert Wallace); Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo, New York (Hailey Banack); Department of Family Medicine and Public Health, School of Medicine, University of California, San Diego, San Diego, California (Aladdin H. Shadyab); Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, California (Lihong Qi); Department of Biostatistics and Data Science, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina (Beverly M. Snively); North American Menopause Society, Mayfield Heights, Ohio (Margery Gass); and Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts (JoAnn E. Manson). This work was supported by the National Cancer Institute (grants R01 CA119171 and R01 CA210921) and by the National Heart, Lung and Blood Institute, which supports the infrastructure of the Women’s Health Initiative (contracts HHSN268201100046C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C, and HHSN271201600004C). R.T.C. reports consulting arrangements with Novartis International AG (Basel, Switzerland), AstraZeneca AB (Cambridge, United Kingdom), Amgen, Inc. (Thousand Oaks, California), Immunomedics (Morris Plains, New Jersey), Puma Biotechnology, Inc. (Los Angeles, California), and Genentech, Inc. (South San Francisco, California). The other authors have no pertinent disclosures.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85089811594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089811594&partnerID=8YFLogxK

U2 - 10.1093/aje/kwaa032

DO - 10.1093/aje/kwaa032

M3 - Comment/debate

C2 - 32314786

AN - SCOPUS:85089811594

VL - 189

SP - 985

EP - 986

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 9

ER -